EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis
Author:
Affiliation:
1. Department of Otorhinolaryngology-Head and Neck Surgery; University of Pennsylvania, Perelman School of Medicine; Philadelphia PA
2. Oregon Allergy Associates; Eugene OR
3. OptiNose US, Inc.; Yardley PA
4. OptiNose AS, Oslo; Norway
Funder
OptiNose US, Inc
Publisher
Wiley
Subject
Otorhinolaryngology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/alr.22141/fullpdf
Reference44 articles.
1. Chronic rhinosinusitis: epidemiology and medical management;Hamilos;J Allergy Clin Immunol,2011
2. Epidemiology and economic impact of rhinosinusitis;Anand;Ann Otol Rhinol Laryngol Suppl,2004
3. Healthcare for chronic rhinosinusitis (CRS) symptoms - a cross-sectional population-based survey of U.S. adults meeting symptom criteria for CRS;Mahmoud;J Allergy Clin Immunol,2017
4. Cost of adult chronic rhinosinusitis: a systematic review;Smith;Laryngoscope,2015
5. European Position Paper on Rhinosinusitis and Nasal Polyps 2012;Fokkens;Rhinol Suppl,2012
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. EDS‐FLU efficacy in patients with chronic rhinosinusitis with or without prior sinus surgery in ReOpen1 and ReOpen2 randomized controlled trials;International Forum of Allergy & Rhinology;2024-08-26
2. Reply to “Considerations of clinical trial design to evaluate intranasal corticosteroids in patients with chronic rhinosinusitis”;The Journal of Allergy and Clinical Immunology: In Practice;2024-07
3. Comparative study of nasal cavity drug delivery efficiency with different nozzles in a 3D printed model;PeerJ;2024-04-10
4. Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2);The Journal of Allergy and Clinical Immunology: In Practice;2024-04
5. Unblocking the Treatment Stalemate in Chronic Rhinosinusitis Without Nasal Polyposis (CRSsNP);The Journal of Allergy and Clinical Immunology: In Practice;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3